ICL Group Ltd. Files January 2025 6-K Report

Ticker: ICL · Form: 6-K · Filed: Jan 22, 2025 · CIK: 941221

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

ICL Group Ltd. filed their January 6-K, standard foreign issuer report.

AI Summary

ICL Group Ltd. filed a Form 6-K on January 22, 2025, reporting for the month of January 2025. The company, previously known as Israel Chemicals Ltd., is incorporated in Israel and has its principal executive offices in Tel Aviv. This filing is a report of a foreign private issuer under the Securities Exchange Act of 1934.

Why It Matters

This filing provides routine updates for investors and the market regarding ICL Group Ltd.'s status as a foreign private issuer. It confirms their ongoing reporting obligations with the SEC.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial results or material events.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country or that it has filed or is required to file with a stock exchange.

When was ICL Group Ltd. previously known as?

ICL Group Ltd. was previously known as Israel Chemicals Ltd.

Where are ICL Group Ltd.'s principal executive offices located?

ICL Group Ltd.'s principal executive offices are located in Tel Aviv, Israel.

Does ICL Group Ltd. file annual reports under Form 20-F or 40-F?

ICL Group Ltd. files annual reports under Form 20-F.

What is the Commission File Number for ICL Group Ltd.?

The Commission File Number for ICL Group Ltd. is 001-13742.

Filing Stats: 4,785 words · 19 min read · ~16 pages · Grade level 13 · Accepted 2025-01-22 16:07:44

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number: 001-13742 ICL GROUP LTD. (Exact name of registrant as specified in its charter) ICL Group Ltd. Millennium Tower 23 Aranha Street P.O. Box 20245 Tel Aviv, 61202 Israel (972-3) 684-4400 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F ICL GROUP LTD. INCORPORATION BY REFERENCE This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of ICL Group Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. In addition, this report on Form 6-K shall be deemed to be incorporated by reference into the Israeli Shelf Prospectus of ICL Group Ltd. filed with the Israel Securities Authority and dated February 28, 2022 (Filing Number: 2022-02-019821) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. ICL GROUP LTD. 1. Notice and Proxy Statement for Extraordinary General Meeting of Shareholders to be held on March 6, 2025 www.icl-group.com ICL GROUP LTD. NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Thursday, March 6, 2025 IMPACT FOR A SUSTAINABLE FUTURE NOTICE OF GENERAL MEETING OF SHAREHOLDERS 02/27 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Notice is hereby given that an Extraordinary General Meeting of Shareholders (the "Meeting") of ICL Group Ltd. (the "Company") will be held on Thursday, March 6, 2025, at 10:00 a.m. (Israel time), at the offices of the Company, Millennium Tower, 23 Aranha Street, 22nd Floor, Tel Aviv, Israel, or via Microsoft Teams at https://teams.microsoft.com/l/meetup-join/19%3ameeting_MmQxMmViMTUtYWZiNy00Y2U2LTg2MzMtOGUw MjdlNjRjYjdh%40thread.v2/0?context=%7b%22Tid%22%3a%22802762d2-02c4-4677-98ba-54060a234204%22%2c%22 Oid%22%3a%2222e45515-b4cf-46f7-bd8e-02d2af6f2692%22%7d, for the following purposes: (1) Approval of the compensation terms for the newly appointed President & Chief Executive Officer of the Company, Mr. Elad Aharonson; (2) Approval of the grant of an equity-based award to the newly appointed President & Chief Executive Officer of the Company, Mr. Elad Aharonson; (3) Approval of the renewal of the compensation terms of the Executive Chairman of the Board of Directors of the Company, Mr. Yoav Doppelt; and (4) Approval of the grant of an equity-based award to the Executive Chairman of the Board of Directors of the Company, Mr. Yoav Doppelt. Our Board of Directors recommends that you vote "FOR" each of the proposals that are described in the attached Proxy you are entitled to receive notice of, and to vote in person or by proxy at, the Meeting or any adjournment or postponement thereof. This also applies if you held ordinary shares through a bank, broker, or other nominee (i.e., in "street name") that is one of our shareholders of record at the close of business on the Record Date, or which appeared in the participant listing of a securities depository (such as the Depository Trust Company) on that date. If you held our ordinary shares through the Tel Aviv Stock Exchange ("TASE") on the Record Date, you are also entitled to notice of the Meeting and to vote at the Meeting or any adjournment or postponement thereof. The accompanying proxy statement includes important information about the Meeting and the voting process. Please read it carefully and remember to cast your vote. 03/27 NOTICE OF GENERAL MEETING OF SHAREHOLDERS NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Record holders: Shareholders of record can vote either by mailing in a proxy or in person by attending the Meeting. If you are a shareholder of record and will not attend the Meeting in person, you are requested to complete, date, and sign the enclosed form of proxy and return it promptly, no later than 48 hours before the Meeting, in the pre-addressed envelope provided. No postage is required if mailed in the United States. If you are a shareholder of record and attend the Meeting, you may revoke your proxy (if previously submitted) and vote in person. Beneficial holders: If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the beneficial owner of shares held in "street name". Your broker, bank, or nominee will provide you with instructions that you must follow to have your shares voted. If you are a beneficial holder and wish to vote in person at the Meeting, you must first obtain a "legal proxy" from your broker, bank, or nominee that holds your

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing